Abstract:
The invention provides a method for determining the concentration of virus particles and/or virus antigens in a sample. In particular, the invention relates to determining the concentration of influenza virus particles/influenza virus antigens in a sample. The invention further relates to the use of an ion-exchange matrix for the determination of the concentration of virus particles and/or virus antigens in a sample.
Abstract:
The invention provides quinazoline compounds that are inhibitors of PDKl. Also provided are pharmaceutical compositions including the compounds, and methods of treating proliferative diseases, such as cancers, with the compounds or compositions.
Abstract:
Assays for detection of bactericidal anti-Neisserial antibodies using a factor H polypeptide having a human amino acid sequence that mediates binding to Neisserial factor H binding protein (fhBp) are provided, as well as non-human animal models of Neisserial infection.
Abstract:
The invention provides, inter alia, methods for treating cancer, compositions for treating cancer, and methods and compositions for diagnosing and/or detecting cancer. In particular, the present invention provides compositions and methods for treating, diagnosing and detecting cancers associated with LIV-1 overexpression.
Abstract:
The present invention provides methods of analyzing the identity and purity of 4-ammo-5-fluoro-3-[5-(4-methylpiperazin-1-y1)-lH-benzimidazol-2-yl]quinolin-2(lH)-one as a bulk drug substance and as the active pharmaceutical ingredient in various pharmaceutical formulations. The methods include both HPLC and thermogravimetric methods.